Thai PBS Thai PBS
Human trials of Thailand’s first COVID protein subunit vaccine to begin in September

Human trials of Thailand’s first COVID protein subunit vaccine to begin in September

13 Sept 07:18 Key points summarised by AI
  • Thailand's first COVID-19 protein subunit vaccine, developed by Chulalongkorn University and Baiya Phytopharm, is set to begin human trials in September.
  • The initial phase will involve 100 volunteers testing three different dosages, with mass production potentially starting in the third quarter of next year.
  • A new 160 million baht factory, approved by the Thai FDA, will produce up to 5 million doses monthly using a unique tobacco leaf-based process.
  • Pre-clinical trials showed satisfactory immune responses, and the vaccine is designed to be adaptable to new viral variants, similar to anti-flu vaccines.
Read full article
Thai PBS World 1/1
Skip > Skip >